Mckesson (MCK) Return on Capital Employed (2009 - 2026)
Mckesson (MCK) reported Return on Capital Employed of 38.25% for Q1 2026, down 18.0% year-over-year from 46.65% in Q1 2025, and up 8.57% quarter-over-quarter from 35.23% in Q4 2025.
Mckesson (MCK) Return on Capital Employed (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 18 years of Return on Capital Employed data on file, last reported at 38.25% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 38.25%, down 18.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 38.25% (down 18.0% YoY), and the FY2026 annual result was 53.03%, up 738.0% from the prior year.
- Return on Capital Employed climbed to 38.25% in Q1 2026 per MCK's latest filing, from 35.23% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 38.43% in Q1 2025 and troughed at 13.55% in Q1 2022.
- A 5-year average of 28.62% and a median of 30.06% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2024: Return on Capital Employed surged 5211 bps in 2022, then sank 454 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 27.11% in 2022, then declined by 7 bps to 25.09% in 2023, then gained by 22 bps to 30.68% in 2024, then grew by 15 bps to 35.23% in 2025, then gained by 9 bps to 38.25% in 2026.
- Business Quant data shows MCK's Return on Capital Employed at 38.25% in Q1 2026, 35.23% in Q4 2025, and 35.76% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 38.25% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 11.68% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 15.02% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 8.29% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -1.96% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -67.42% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -0.62% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -18.00% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.25% |
| Dec 31, 2025 | 35.23% |
| Sep 30, 2025 | 35.76% |
| Jun 30, 2025 | 31.88% |
| Mar 31, 2025 | 38.43% |
| Dec 31, 2024 | 30.68% |
| Sep 30, 2024 | 26.09% |
| Jun 30, 2024 | 29.25% |
| Mar 31, 2024 | 26.74% |
| Dec 31, 2023 | 25.09% |
| Sep 30, 2023 | 30.63% |
| Jun 30, 2023 | 30.06% |
| Mar 31, 2023 | 30.11% |
| Dec 31, 2022 | 27.11% |
| Sep 30, 2022 | 21.57% |
| Jun 30, 2022 | 16.07% |
| Mar 31, 2022 | 13.55% |
| Dec 31, 2021 | 14.91% |
| Sep 30, 2021 | -30.54% |
| Jun 30, 2021 | -25.60% |